SCHEMBL27446226

SCHEMBL27446226

N=C(N)NCc1ccc(OCOCCCOCOOOCCOCNCCCNCCCOc2c(I)cc(Oc3c(I)cc(CC(=O)O)cc3I)cc2I)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 6/20 0.43
▸ ITGAV P06756 6/20 0.43
▸ THRA P10827 3/20 0.36
▸ THRB P10828 3/20 0.36
▸ PPARG P37231 3/20 0.36
▸ RXRA P19793 2/20 0.36
▸ ABCB11 O95342 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ AR P10275 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ PCNA P12004 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27446344 0.91 ITGB3 (0.46) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL27446346 0.89 ITGB3 (0.44) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL21101049 0.85 ITGB3 (0.54) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL21100868 0.84 ITGB3 (0.55) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL27446221 0.84 ITGB3 (0.48) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL23709969 0.76 ITGB3 (0.54) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL21100863 0.76 ITGB3 (0.45) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL12764506 0.71 THRB (0.57) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL21100869 0.70 ITGB3 (0.46) ITGB3ITGAVTHRATHRBPPARG
SCHEMBL19679634 0.70 THRB (0.60) ITGB3ITGAVTHRATHRBPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3773540-B1 COMPOSITION AND METHOD FOR DUAL TARGETING IN TREATMENT OF NEUROENDOCRINE TUMORS NANOPHARMACEUTICALS LLC (US) 2024-07-03 — — EP disclosed
Send feedback